Global Angiotensin Converting Enzyme (ACE) Inhibitors Market – Industry Trends and Forecast to 2028

  • Healthcare
  • Upcoming Report
  • Dec 2020
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Angiotensin Converting Enzyme (ACE) Inhibitors Market, By Product Type (Dicarboxylate-Containing Agents, Phosphonate-Containing Agents, Sulfhydryl-Containing Agents), Drug (Lisinopril, Ramipril, Enalapril, Benazepril, Fosinopril, Captopril, Moexipril,  Others), Dosage Form (Oral Tablets, Oral Solution), Application (Heart Failure, Hypertension, Diabetes, Heart Attack, Chronic Kidney Disease, Others), Distribution Channel (Retail Pharmacy, Hospital Pharmacy, E-Commerce Websites, Online Drug Stores), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028

Angiotensin Converting Enzyme (ACE) Inhibitors Market Market Analysis and Insights of Angiotensin Converting Enzyme (ACE) Inhibitors Market

Angiotensin converting enzyme (ACE) inhibitors market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to account to USD 8,520.26 million by 2028 and will grow at a CAGR of 3.87% in the above mentioned forecast period.

The rapidly increasing incidence of cardiovascular diseases is amongst the essential factors intensifying the growth and demand of angiotensin converting enzyme (ACE) inhibitors market. In addition, rise in prevalence of high blood pressure is also contributing to rising in the global market. The growing risk of developing high blood pressure and cardiovascular disorders due to the changing lifestyle is also the key factor flourishing angiotensin converting enzyme (ACE) inhibitors market trends over the forecast period of 2021 to 2028. Likewise, the angiotensin converting enzyme inhibitors broaden the blood vessels by lowering the amount of angiotensin II in the body. These inhibitors also increase the amount of urine produced by kidneys. These results help lower pressure in the lowering blood volume, kidney and blood pressure and are also exceedingly influencing the growth of the angiotensin converting enzyme (ACE) inhibitors market.

Some other major drivers expected to fuel this market's growth are the various evidence from clinical trials has shown that angiotensin converting enzyme inhibitors have the positive impact of any drug in cardiovascular medicine, dropping the risk of death, myocardial infarction, diabetes, stroke and renal impairment. They help patients with heart failure or left ventricular dysfunction, peripheral vascular disease, post-myocardial infarction, diabetes, stroke, transient ischaemic attack, or coronary artery disease, thus lifting the growth of the target market in the above mentioned forecast period. Also the developed healthcare infrastructure, high public awareness associated with diagnosis, treatment and management of lifestyle diseases also fuel market growth.

The various major pharmaceutical companies are developing innovative products which will further accelerate the expansion of the angiotensin converting enzyme (ACE) inhibitors market and are also are offering significant growth opportunities for the market in the forecast period of 2021 to 2028. However, the high cost of the product will restrict the growth of the angiotensin converting enzyme (ACE) inhibitors market.

This angiotensin converting enzyme (ACE) inhibitors market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on angiotensin converting enzyme (ACE) inhibitors market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Angiotensin Converting Enzyme (ACE) Inhibitors Market Scope and Market Size

Angiotensin converting enzyme (ACE) inhibitors market is segmented on the basis of product type, drug, dosage form, application and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

  • On the basis of product type, the angiotensin converting enzyme (ACE) inhibitors market is segmented into dicarboxylate-containing agents, phosphonate-containing agents and sulfhydryl-containing agents.
  • On the basis of drug, the angiotensin converting enzyme (ACE) inhibitors market is segmented into ramipril, enalapril, benazepril, fosinopril, captopril, moexipril and others.
  • Based on dosage form, the angiotensin converting enzyme (ACE) inhibitors market is segmented into oral tablets and oral solution.
  • On the basis of application, the angiotensin converting enzyme (ACE) inhibitors market is segmented into heart failure, hypertension, diabetes, heart attack, chronic kidney disease and others.
  • The distribution channel segment of the angiotensin converting enzyme (ACE) inhibitors market is segmented into retail pharmacy, hospital pharmacy, e-commerce websites and online drug stores.

Angiotensin Converting Enzyme (ACE) Inhibitors Market Country Level Analysis

Angiotensin converting enzyme (ACE) inhibitors market is analyzed and market size insights and trends are provided by country, product type, drug, dosage form, application and distribution channel as referenced above.

The countries covered in the angiotensin converting enzyme (ACE) inhibitors market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa(MEA), Brazil, Argentina and Rest of South America as part of South America.

North America region leads the angiotensin converting enzyme (ACE) inhibitors market owing to the growing prevalence of hypertension within the region. Asia-Pacific is expected to expand at a significant growth rate over the forecast period of 2021 to 2028 owing to the growing cardiac diseases in emerging countries like China and India in this region.

The country section of the angiotensin converting enzyme (ACE) inhibitors market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure growth Installed base and New Technology Penetration

Angiotensin converting enzyme (ACE) inhibitors market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for angiotensin converting enzyme (ACE) inhibitors market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the angiotensin converting enzyme (ACE) inhibitors market. The data is available for historic period 2010 to 2019.

Competitive Landscape and Angiotensin Converting Enzyme (ACE) Inhibitors Market Share Analysis

Angiotensin converting enzyme (ACE) inhibitors market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to angiotensin converting enzyme (ACE) inhibitors market.

The major players covered in the angiotensin converting enzyme (ACE) inhibitors market report are Abbott, Bausch Health Companies Inc., AbbVie Inc., Pfizer Inc., DAIICHI SANKYO COMPANY, LIMITED, Novartis AG, Merck KGaA, La Jolla Pharmaceutical Company, Quantum Genomics, AstraZeneca, Johnson & Johnson Services, Inc., Eli Lilly and Company, Par Pharmaceutical, Sanofi, Bristol-Myers Squibb Company, Sandoz AG, Mayo Foundation for Medical Education and Research (MFMER), Bayer AG, Takeda Pharmaceutical Company Limited, GlaxoSmithKline plc and Teva Pharmaceutical Industries Ltd., among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Customization Available : Global Angiotensin Converting Enzyme (ACE) Inhibitors Market

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

CHOOSE LICENCE TYPE
  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions



Frequently Asked Questions